Exelixis Inc (NAS:EXEL)
$ 20.985 0.075 (0.36%) Market Cap: 6.11 Bil Enterprise Value: 5.32 Bil PE Ratio: 32.64 PB Ratio: 2.91 GF Score: 91/100

Exelixis Inc at RBC Capital Markets Global Healthcare Conference Transcript

May 17, 2022 / 12:30PM GMT
Release Date Price: $20.69 (+2.12%)
Gregory James Renza
RBC Capital Markets, Research Division - Analyst

Good morning, everyone, and welcome back to the 2022 RBC Global Healthcare Conference. My name is Greg Renza, one of the senior biotechnology equity research analysts here, and we're pleased to have Exelixis with us today. And joining us from the company is the EVP and CFO, Chris Senner; as well as the SVP of Strategy, Andrew Peters. Guys, thanks for joining us this morning.

Christopher J. Senner
Exelixis, Inc. - Executive VP & CFO

Great. Thanks for having us. And excited to be here, sir, one of the few times we've been in public, not doing this via Zoom. So it's great to see everybody.

Gregory James Renza;Christopher J. Senner
RBC Capital Markets, Research Division - Analyst;Exelixis, Inc. -

Yes, absolutely. It's great to be in person again. And maybe, Chris, we can just kick off by having you give us on the audience a quick overview of Exelixis and what the pipeline is and what '22 has and will look like?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot